Response to: Safety and efficacy considerations of HSC-based gene therapy for RAG1-deficient SCID

Response to: Safety and efficacy considerations of HSC-based gene therapy for RAG1-deficient SCID / Montini, E., Naldini, L., Booth, C., Kohn, D.B., Aiuti, A.. - In: MOLECULAR THERAPY. - ISSN 1525-0016. - 33:5(2025), pp. 1871-1871. [10.1016/j.ymthe.2025.03.049]